Integral Diagnostics Toekomstige groei
Future criteriumcontroles 4/6
Integral Diagnostics zal naar verwachting groeien in winst en omzet met respectievelijk 89.3% en 6.6% per jaar. De winst per aandeel zal naar verwachting groeien met 89.5% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 12.7% zijn.
Belangrijke informatie
89.3%
Groei van de winst
89.5%
Groei van de winst per aandeel
| Healthcare winstgroei | 25.2% |
| Inkomstengroei | 6.6% |
| Toekomstig rendement op eigen vermogen | 12.7% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 03 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital
Feb 21
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being
Nov 22Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year
Feb 20These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively
Dec 14Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?
May 26Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year
Feb 28Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate
Feb 25Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why
Oct 29Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?
Sep 13An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued
Jun 04Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?
May 14Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?
May 03We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt
Apr 16Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Mar 27Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?
Mar 17The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About
Mar 07Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend
Feb 25Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?
Feb 23Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?
Feb 13Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price
Feb 03
Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)
Jan 24Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?
Jan 14Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return
Jan 05Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Dec 26At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?
Dec 17What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend
Dec 08Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture
Nov 29Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?
Nov 19Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2027 | 574 | 43 | 94 | 116 | 3 |
| 6/30/2026 | 538 | 31 | 63 | 87 | 6 |
| 6/30/2025 | 505 | 23 | 52 | 79 | 6 |
| 6/30/2024 | 470 | -61 | 42 | 66 | N/A |
| 3/31/2024 | 463 | -59 | 29 | 62 | N/A |
| 12/31/2023 | 456 | -58 | 20 | 62 | N/A |
| 9/30/2023 | 449 | -16 | 24 | 67 | N/A |
| 6/30/2023 | 441 | 25 | 23 | 67 | N/A |
| 3/31/2023 | 418 | 23 | 20 | 56 | N/A |
| 12/31/2022 | 395 | 21 | 17 | 45 | N/A |
| 9/30/2022 | 378 | 18 | 13 | 41 | N/A |
| 6/30/2022 | 361 | 15 | 9 | 37 | N/A |
| 3/31/2022 | 361 | 18 | 14 | 41 | N/A |
| 12/31/2021 | 360 | 22 | 18 | 44 | N/A |
| 9/30/2021 | 356 | 26 | 34 | 57 | N/A |
| 6/30/2021 | 351 | 31 | 49 | 70 | N/A |
| 3/31/2021 | 333 | 32 | 54 | 73 | N/A |
| 12/31/2020 | 315 | 32 | 59 | 76 | N/A |
| 9/30/2020 | 295 | 28 | 44 | 65 | N/A |
| 6/30/2020 | 276 | 23 | 28 | 54 | N/A |
| 3/31/2020 | 263 | 22 | 19 | 47 | N/A |
| 12/31/2019 | 250 | 21 | 9 | 39 | N/A |
| 9/30/2019 | 241 | 21 | 12 | 37 | N/A |
| 6/30/2019 | 232 | 21 | 15 | 34 | N/A |
| 3/31/2019 | 222 | 19 | 14 | 30 | N/A |
| 12/31/2018 | 211 | 17 | 13 | 26 | N/A |
| 9/30/2018 | 200 | 16 | 14 | 26 | N/A |
| 6/30/2018 | 189 | 15 | 15 | 27 | N/A |
| 3/31/2018 | 187 | 15 | N/A | 27 | N/A |
| 12/31/2017 | 185 | 15 | N/A | 27 | N/A |
| 9/30/2017 | 182 | 15 | N/A | 25 | N/A |
| 6/30/2017 | 180 | 15 | N/A | 23 | N/A |
| 3/31/2017 | 177 | 16 | N/A | 26 | N/A |
| 12/31/2016 | 175 | 16 | N/A | 30 | N/A |
| 9/30/2016 | 171 | 14 | N/A | 27 | N/A |
| 6/30/2016 | 168 | 11 | N/A | 24 | N/A |
| 3/31/2016 | 165 | 11 | N/A | 22 | N/A |
| 12/31/2015 | 162 | 11 | N/A | 20 | N/A |
| 9/30/2015 | 157 | 8 | N/A | 18 | N/A |
| 6/30/2015 | 151 | 5 | N/A | 17 | N/A |
| 6/30/2014 | 4 | 3 | N/A | 4 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Er wordt voorspeld dat IDX de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 2.6% ).
Winst versus markt: Er wordt verwacht dat IDX de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.
Hoge groeiwinsten: Er wordt verwacht dat IDX binnen 3 jaar winstgevend zal worden.
Omzet versus markt: De omzet van IDX ( 6.6% per jaar) zal naar verwachting sneller groeien dan de markt Australian ( 5.7% per jaar).
Hoge groei-inkomsten: De omzet van IDX ( 6.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen IDX zal naar verwachting over 3 jaar laag zijn ( 12.7 %).